Literature DB >> 9363706

Induction of messenger RNA for the 70 kDa heat shock protein in HeLa cells and the human endocervix following exposure to semen: implications for antisperm antibody production and susceptibility to sexually transmitted infections.

J Jeremias1, S S David, M Toth, S S Witkin.   

Abstract

The 70 kDa heat shock protein (HSP70) is induced in cells exposed to chemical or physical stress. HSP70 facilitates cell survival by preventing protein denaturation and incorrect assembly of polypeptides. Induction of HSP70 messenger RNA (mRNA) synthesis also inhibits transcription of genes coding for pro-inflammatory cytokines. We analyzed whether HSP70 mRNA was expressed in a cultured human cervical cell line (HeLa cells) following exposure to human semen, or in cells obtained from the endocervices of sexually active women. HeLa cells were co-cultured with a 1:50 dilution of semen from four men, with purified spermatozoa, or with cell-free seminal fluid. Endocervical swabs were obtained at mid-cycle from 53 women. HSP70 mRNA was detected in HeLa cells by a reverse transcriptase-polymerase chain reaction (RT-PCR) and analysis on agarose gels. HSP70 mRNA in cervical cells was measured by RT-PCR followed by hybridization with an HSP70-specific internal probe and detection by ELISA. Cervical IgA antibodies to HSP70 were measured by ELISA. HeLa cell-semen co-culture led in each case to induction of HSP70 mRNA. Cell-free seminal fluid and isolated motile spermatozoa also induced HSP70 mRNA when incubated individually with HeLa cells. HSP70 mRNA was detected in 28 (52.8%) of 53 endocervical cell samples obtained from women at varying times after sexual intercourse. The percentage of samples expressing HSP70 mRNA was 37.5% at <10 h, 64.3% at 10 h, 70.0% at 11 h and between 36 and 50% at later times after semen exposure. Cervical IgA antibodies to HSP70 were also detected in some women and their occurrence was highly correlated with HSP70 gene transcription (P < 0.0001). The data demonstrate that exposure to semen induces HSP70 mRNA in endocervical cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363706     DOI: 10.1093/humrep/12.9.1915

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells.

Authors:  Kurt J Sales; Arieh A Katz; Robert P Millar; Henry N Jabbour
Journal:  Mol Hum Reprod       Date:  2002-12       Impact factor: 4.025

2.  Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway.

Authors:  S Battersby; K J Sales; A R Williams; R A Anderson; S Gardner; H N Jabbour
Journal:  Hum Reprod       Date:  2006-08-12       Impact factor: 6.918

3.  Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo.

Authors:  Jason R Sutherland; Kurt J Sales; Henry N Jabbour; Arieh A Katz
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

4.  Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway.

Authors:  Anthonio O Adefuye; Kurt J Sales; Arieh A Katz
Journal:  J Mol Signal       Date:  2014-08-08

5.  Retracted: Induction of Heat Shock Protein Expression in Cervical Epithelial Cells by Human Semen.

Authors:  Infectious Diseases In Obstetrics And Gynecology
Journal:  Infect Dis Obstet Gynecol       Date:  2017-11-13

6.  Inflammatory Cytokine Profiles of Semen Influence Cytokine Responses of Cervicovaginal Epithelial Cells.

Authors:  Cosnet L Rametse; Anthonio O Adefuye; Abraham J Olivier; Lyle Curry; Hoyam Gamieldien; Wendy A Burgers; David A Lewis; Anna-Lise Williamson; Arieh A Katz; Jo-Ann S Passmore
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.